LifeVantage (NASDAQ:LFVN) Share Price Crosses Above 200-Day Moving Average of $6.34

LifeVantage Co. (NASDAQ:LFVNGet Free Report)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.34 and traded as high as $7.01. LifeVantage shares last traded at $6.98, with a volume of 48,626 shares trading hands.

LifeVantage Stock Performance

The business has a 50-day moving average of $6.08 and a 200-day moving average of $6.35. The stock has a market capitalization of $90.22 million, a price-to-earnings ratio of 30.48 and a beta of 0.73.

LifeVantage (NASDAQ:LFVNGet Free Report) last issued its quarterly earnings data on Tuesday, January 30th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $51.62 million during the quarter. LifeVantage had a return on equity of 19.96% and a net margin of 1.40%.

LifeVantage Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 15th. Investors of record on Friday, March 1st will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date of this dividend is Thursday, February 29th. LifeVantage’s payout ratio is 60.87%.

Hedge Funds Weigh In On LifeVantage

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Northern Trust Corp boosted its holdings in LifeVantage by 90.0% during the 4th quarter. Northern Trust Corp now owns 36,280 shares of the company’s stock valued at $218,000 after acquiring an additional 17,189 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of LifeVantage by 11.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 313,378 shares of the company’s stock valued at $1,880,000 after buying an additional 31,746 shares during the period. Ritholtz Wealth Management boosted its stake in shares of LifeVantage by 23.5% in the 4th quarter. Ritholtz Wealth Management now owns 25,027 shares of the company’s stock valued at $150,000 after buying an additional 4,756 shares during the period. Walleye Capital LLC purchased a new position in shares of LifeVantage in the 3rd quarter valued at about $129,000. Finally, O Shaughnessy Asset Management LLC boosted its stake in shares of LifeVantage by 135.4% in the 3rd quarter. O Shaughnessy Asset Management LLC now owns 48,506 shares of the company’s stock valued at $313,000 after buying an additional 27,897 shares during the period. 35.66% of the stock is currently owned by hedge funds and other institutional investors.

LifeVantage Company Profile

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Featured Stories

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.